Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

6533b86dfe1ef96bd12ca1ff

RESEARCH PRODUCT

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Jordi Carratalà Jordi Carratalà Elisa Cordero Pilar Martín-dávila Nicolás Manito E. Frauca Daniela Paredes Hernandez J. Torre-cisneros Juan José Castón Juan José Castón Sara Cantisán A. Rodriguez-bernot David Navarro E. Vidal Oscar Len Oscar Len José Rumbao Ignacio Herrero Miguel Montejo José M. Vaquero Patricia Muñoz Carlos Cervera Joan Gavaldà Joan Gavaldà A. Moreno R. San Juan R. San Juan María Carmen Fariñas María Carmen Fariñas J. Fortún Víctor Monforte Alejandro Alonso Francisco López-medrano Mario Fernández-ruiz Pilar Pérez-romero Luis Almenar M. A. Marcos José María Aguado José María Aguado

subject

medicine.medical_specialty Congenital cytomegalovirus infection MEDLINE Drug resistance 030230 surgery Antiviral Agents Organ transplantation 03 medical and health sciences 0302 clinical medicine Monitoring Immunologic Medicine Humans Major complication Intensive care medicine Transplantation business.industry Organ Transplantation medicine.disease Transplant Recipients Cytomegalovirus infection Clinical microbiology Immunology Cytomegalovirus Infections Practice Guidelines as Topic 030211 gastroenterology & hepatology business Solid organ transplantation

description

Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant centers, in 2011 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, new publications have clarified or questioned the aspects covered in the previous document. For that reason, a panel of experts revised the evidence on CMV management, including immunological monitoring, diagnostics, prevention, vaccines, indirect effects, treatment, drug resistance, immunotherapy, investigational drugs, and pediatric issues. This document summarizes the recommendations.

year	journal	country	edition	language
2016-07-01	Transplantation reviews (Orlando, Fla.)

10.1016/j.trre.2016.04.001 https://pubmed.ncbi.nlm.nih.gov/27132815